T2 Biosystems to Appear on the Benzinga All Access Show on June 17, 2022
T2 Biosystems (NASDAQ:TTOO) announced its appearance on the Benzinga All Access show on June 17, 2022, where management will be interviewed at 9:40 AM ET. The live and recorded broadcast will be accessible via T2 Biosystems’ Investor Relations website. T2 Biosystems specializes in rapid detection of sepsis-causing pathogens and antibiotic resistance genes, aiming to enhance patient care. Their products include various diagnostic panels powered by T2 Magnetic Resonance technology, with future products in development.
- Scheduled interview on Benzinga All Access for increased visibility.
- Focus on rapid detection technologies aligns with healthcare needs.
- None.
LEXINGTON, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to appear on the Benzinga All Access show on Friday, June 17, 2022.
Management is scheduled to be interviewed that day at 9:40am ET. A link to the live and recorded YouTube broadcast will be available on the Events & Presentations section of the T2 Biosystems’ Investor Relations website http://investors.t2biosystems.com.
About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, the T2Resistance® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat™ Panel, the T2Cauris™ Panel, and T2Lyme™ Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers.
Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406
FAQ
What is T2 Biosystems' stock symbol?
When will T2 Biosystems appear on the Benzinga All Access show?
What technologies does T2 Biosystems specialize in?
What time is T2 Biosystems' interview scheduled for?
